Effectiveness of tenofovir/emtricitabine versus zidovudine/lamivudine in combination with efavirenz in antiretro viral-naive HIV infected patients / Siti Mahanim Shaik Ismail

Durable suppression of replication of the human immunodeficiency virus (HIV) depends on the use of potent, well-tolerated antiretroviral regimens to which patients can easily adhere. Combination of two NRTIs and one NNRTI is the best first line regimen in treating retroviral disease (RVD) as compare...

Full description

Bibliographic Details
Main Author:	Shaik Ismail, Siti Mahanim
Format:	Thesis
Language:	English
Published:	2015
Subjects:	AIDS. HIV infections
Online Access:	http://ir.uitm.edu.my/id/eprint/21863/ http://ir.uitm.edu.my/id/eprint/21863/1/TM_SITI%20MAHANIM%20SHAIK%20ISMAIL%20PH%20B%2015_5.pdf

id	uitm-21863
recordtype	eprints
spelling	uitm-218632018-10-23T02:22:52Z http://ir.uitm.edu.my/id/eprint/21863/ Effectiveness of tenofovir/emtricitabine versus zidovudine/lamivudine in combination with efavirenz in antiretro viral-naive HIV infected patients / Siti Mahanim Shaik Ismail Shaik Ismail, Siti Mahanim AIDS. HIV infections Durable suppression of replication of the human immunodeficiency virus (HIV) depends on the use of potent, well-tolerated antiretroviral regimens to which patients can easily adhere. Combination of two NRTIs and one NNRTI is the best first line regimen in treating retroviral disease (RVD) as compared to combinations of other groups. Tenofovir and Zidovudine are the two drugs that mostly use as one of NNRTIs in combination with either Lamivudine or Emtricitabine. Review of previous literature had shown that there were conflicting data on the superiority of either regime based on virologic and immunologic response. A local, retrospective observational cohort study was conducted to evaluate the virological response (primary endpoint), immunological response and the safety profile between TDF and AZT regimens. A total of 154 ART-nai've samples from HTAR and HSB were recruited. No statistically significant differences were observed in HIV RNA suppression at 24 weeks and 48 weeks (p = 0.407 and p = 0.521, respectively). Mean difference in CD4 increments were also not significant (p = 0.54, 95% CI -59.97, 31.83 at week 24; p = 0.68, 95% CI -51.41, 33.59 at week 48). However, AZT was found with more adverse events that leads to discontinuation (p-value <0.001). There were two cases of virological failure in TDF group but the association was not significant (p = 0.497). Only education level was identified as predictor of therapy effectiveness. Although there was no significant difference in virological and immunological responses, TDF still has advantage over AZT because of its better safety profile 2015 Thesis NonPeerReviewed text en http://ir.uitm.edu.my/id/eprint/21863/1/TM_SITI%20MAHANIM%20SHAIK%20ISMAIL%20PH%20B%2015_5.pdf Shaik Ismail, Siti Mahanim (2015) Effectiveness of tenofovir/emtricitabine versus zidovudine/lamivudine in combination with efavirenz in antiretro viral-naive HIV infected patients / Siti Mahanim Shaik Ismail. Masters thesis, Universiti Teknologi MARA.
repository_type	Digital Repository
institution_category	Local University
institution	Universiti Teknologi MARA
building	UiTM Institutional Repository
collection	Online Access
language	English
topic	AIDS. HIV infections
spellingShingle	AIDS. HIV infections Shaik Ismail, Siti Mahanim Effectiveness of tenofovir/emtricitabine versus zidovudine/lamivudine in combination with efavirenz in antiretro viral-naive HIV infected patients / Siti Mahanim Shaik Ismail
description	Durable suppression of replication of the human immunodeficiency virus (HIV) depends on the use of potent, well-tolerated antiretroviral regimens to which patients can easily adhere. Combination of two NRTIs and one NNRTI is the best first line regimen in treating retroviral disease (RVD) as compared to combinations of other groups. Tenofovir and Zidovudine are the two drugs that mostly use as one of NNRTIs in combination with either Lamivudine or Emtricitabine. Review of previous literature had shown that there were conflicting data on the superiority of either regime based on virologic and immunologic response. A local, retrospective observational cohort study was conducted to evaluate the virological response (primary endpoint), immunological response and the safety profile between TDF and AZT regimens. A total of 154 ART-nai've samples from HTAR and HSB were recruited. No statistically significant differences were observed in HIV RNA suppression at 24 weeks and 48 weeks (p = 0.407 and p = 0.521, respectively). Mean difference in CD4 increments were also not significant (p = 0.54, 95% CI -59.97, 31.83 at week 24; p = 0.68, 95% CI -51.41, 33.59 at week 48). However, AZT was found with more adverse events that leads to discontinuation (p-value <0.001). There were two cases of virological failure in TDF group but the association was not significant (p = 0.497). Only education level was identified as predictor of therapy effectiveness. Although there was no significant difference in virological and immunological responses, TDF still has advantage over AZT because of its better safety profile
format	Thesis
author	Shaik Ismail, Siti Mahanim
author_facet	Shaik Ismail, Siti Mahanim
author_sort	Shaik Ismail, Siti Mahanim
title	Effectiveness of tenofovir/emtricitabine versus zidovudine/lamivudine in combination with efavirenz in antiretro viral-naive HIV infected patients / Siti Mahanim Shaik Ismail
title_short	Effectiveness of tenofovir/emtricitabine versus zidovudine/lamivudine in combination with efavirenz in antiretro viral-naive HIV infected patients / Siti Mahanim Shaik Ismail
title_full	Effectiveness of tenofovir/emtricitabine versus zidovudine/lamivudine in combination with efavirenz in antiretro viral-naive HIV infected patients / Siti Mahanim Shaik Ismail
title_fullStr	Effectiveness of tenofovir/emtricitabine versus zidovudine/lamivudine in combination with efavirenz in antiretro viral-naive HIV infected patients / Siti Mahanim Shaik Ismail
title_full_unstemmed	Effectiveness of tenofovir/emtricitabine versus zidovudine/lamivudine in combination with efavirenz in antiretro viral-naive HIV infected patients / Siti Mahanim Shaik Ismail
title_sort	effectiveness of tenofovir/emtricitabine versus zidovudine/lamivudine in combination with efavirenz in antiretro viral-naive hiv infected patients / siti mahanim shaik ismail
publishDate	2015
url	http://ir.uitm.edu.my/id/eprint/21863/ http://ir.uitm.edu.my/id/eprint/21863/1/TM_SITI%20MAHANIM%20SHAIK%20ISMAIL%20PH%20B%2015_5.pdf
first_indexed	2023-09-18T23:07:28Z
last_indexed	2023-09-18T23:07:28Z
_version_	1777418579562463232

Effectiveness of tenofovir/emtricitabine versus zidovudine/lamivudine in combination with efavirenz in antiretro viral-naive HIV infected patients / Siti Mahanim Shaik Ismail

Similar Items